Rgs3 — Regulator Of G Protein Signaling 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RGS3 — Regulator of G Protein Signaling 3 is involved in neuronal signaling and synaptic function. [1]
Regulator of G protein Signaling 3 (RGS3) is a member of the RGS protein family, which function as GTPase-activating proteins (GAPs) for heterotrimeric G proteins. RGS proteins accelerate the intrinsic GTPase activity of Gα subunits, thereby rapidly terminating G protein-mediated signaling.
RGS3 is characterized by:
RGS3 is involved in:
RGS3 expression is altered in Alzheimer's disease brains. The protein may:
RGS3 plays a role in dopaminergic signaling and may contribute to PD pathophysiology through:
RGS3 has been implicated in epileptogenesis through its regulation of:
RGS3 shows widespread but specific expression in:
Multiple isoforms are expressed in a tissue-specific manner.
The study of Rgs3 — Regulator Of G Protein Signaling 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Xu X, Bräuer O, Watson KM, et al. RGS3 regulates G protein signaling in the brain. J Neurosci Res. 2021;99(5):1319-1334. 2021. ↩︎